The clinical utility of procainamide-induced late potentials on the signal averaged ECG,Pacing and Clinical Electrophysiology

当前位置： X-MOL 学术 › Pacing Clin. Electrophysiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The clinical utility of procainamide-induced late potentials on the signal averaged ECG
Pacing and Clinical Electrophysiology ( IF 1.7 ) Pub Date : 2021-10-14 , DOI: 10.1111/pace.14379
Charles Michael Pearman _{1,

2} , Jagdeep Walia ₁ , Wael Alqarawi _{1,

3,

4} , Jacob Moesgaard Larsen _{1,

5} , Emma Leach ₁ , Andrew D Krahn ₁ , Zachary Laksman ₁

Affiliation

Late potentials (LPs) identified on the signal averaged electrocardiogram (SAECG) are a marker for an increased risk of arrhythmias in Brugada syndrome (BrS). Procainamide is a sodium channel blocker used to diagnose BrS. The effects of Procainamide on the SAECG in those with BrS and the significance of Procainamide-induced LPs are unknown.

中文翻译：

普鲁卡因胺诱导的晚期电位对信号平均心电图的临床应用

信号平均心电图 (SAECG) 上确定的晚期电位 (LP) 是 Brugada 综合征 (BrS) 心律失常风险增加的标志。普鲁卡因胺是一种钠通道阻滞剂，用于诊断 BrS。普鲁卡因胺对 BrS 患者 SAECG 的影响以及普鲁卡因胺诱导的 LPs 的意义尚不清楚。

更新日期：2021-12-17

点击分享查看原文

点击收藏

阅读更多本刊最新论文